Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year

BACKGROUND AND OBJECTIVES: Some disease-modifying treatments impair response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in multiple sclerosis (MS), potentially increasing the risk of breakthrough infections. We aimed to investigate longitudinal SARS-CoV-2 antibody dynam...

Descripción completa

Detalles Bibliográficos
Autores principales: Disanto, Giulio, Galante, Alice, Cantu', Marco, Sacco, Rosaria, Mele, Federico, Eisler, Jennifer Jessica, Keller, Franco, Bernasconi, Enos, Sallusto, Federica, Zecca, Chiara, Gobbi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747147/
https://www.ncbi.nlm.nih.gov/pubmed/36396447
http://dx.doi.org/10.1212/NXI.0000000000200043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747147/
https://www.ncbi.nlm.nih.gov/pubmed/36396447
http://dx.doi.org/10.1212/NXI.0000000000200043

Ejemplares similares